- Home
- KLRS vs ROC Comparison
KLRS vs ROC Comparison
Compare KLRS & ROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KLRS | ROC |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | United States | United States |
| Employees | 20 | 82 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.0M | 100.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KLRS | ROC |
|---|---|---|
| Price | $4.04 | $4.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $19.00 | $9.00 |
| AVG Volume (30 Days) | ★ 63.9K | 63.2K |
| Earning Date | 05-13-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.14 | $3.71 |
| 52 Week High | $11.88 | $7.80 |
Technical Indicators
Market Signals| Indicator | KLRS | ROC |
|---|---|---|
| Relative Strength Index (RSI) | 37.66 | 46.26 |
| Support Level | N/A | $4.50 |
| Resistance Level | $4.86 | $5.32 |
| Average True Range (ATR) | 0.49 | 0.40 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 15.81 | 12.20 |
Price Performance
Historical ComparisonAbout KLRS Kalaris Therapeutics Inc.
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About ROC Rank One Computing Corporation Common stock
Rank One Computing Corp is an American artificial intelligence company. It develops AI systems that analyze visual data to identify and interpret objects and activities. The company's focus is on biometric identity, digital forensics, and real-time video analytics. It uses the term 'Vision AI,' which is an operational AI built for accuracy, speed, and auditability. The company generates revenue from the sale of access to its software platforms, maintenance services, and professional services.